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ABSTRACT 42 
β2-adrenoceptors and the L-type Ca current (ICa) redistribute from the t-tubules to the surface 43 
membrane of ventricular myocytes from failing hearts. The present study investigated the 44 
role of changes in caveolin-3 (Cav-3) and protein kinase A (PKA) signaling, both of which 45 
have previously been implicated in this redistribution. ICa was recorded using the whole cell 46 
patch clamp technique from ventricular myocytes isolated from the hearts of rats that had 47 
undergone either coronary artery ligation (CAL) or equivalent Sham operation 18 weeks 48 
earlier. ICa distribution between the surface and t-tubule membranes was determined using 49 
formamide-induced detubulation (DT). In Sham myocytes, β2-adrenoceptor stimulation 50 
increased ICa in intact, but not DT myocytes; however, forskolin (to increase cAMP directly) 51 
and H-89 (to inhibit PKA) increased and decreased, respectively, ICa at both the surface and t-52 
tubule membranes. C3SD peptide (which decreases binding to Cav-3) inhibited ICa in intact 53 
but not DT myocytes, but had no effect in the presence of H-89. In contrast, in CAL 54 
myocytes, β2-adrenoceptor stimulation increased ICa in both intact and DT myocytes, but 55 
C3SD had no effect on ICa; forskolin and H-89 had similar effects as in Sham myocytes.  56 
These data show redistribution of β2-adrenoceptor activity and ICa in CAL myocytes, and 57 
suggest constitutive stimulation of ICa by PKA in Sham myocytes via concurrent Cav-3-58 
dependent (at the t-tubules) and Cav-3-independent mechanisms, with the former being lost 59 
in CAL myocytes. 60 
(230 words) 61 
 62 
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NEW AND NOTEWORTHY 63 
In ventricular myocytes from normal hearts, regulation of the L-type Ca
2+
 current by β2-64 
adrenoceptors and the constitutive regulation by caveolin-3 is localized to the t-tubules. In 65 
heart failure, the regulation of L-type Ca
2+
 current by β2-adrenoceptors is redistributed to the 66 
surface membrane and the constitutive regulation by caveolin-3 is lost.67 
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INTRODUCTION 68 
The L-type Ca
2+
 current (ICa) plays a key role in excitation-contraction (EC) coupling in 69 
cardiac ventricular myocytes: activation of L-type Ca
2+
 channels (LTCCs) during the action 70 
potential causes influx of Ca
2+
 that triggers Ca
2+
 release via ryanodine receptors (RyRs) in the 71 
adjacent sarcoplasmic reticulum (SR) membrane (2, 8). Previous work has shown that the 72 
function of many of the key proteins involved in EC coupling, including the LTCCs and 73 
RyRs, occurs predominantly at the t-tubules: invaginations of the surface membrane which 74 
enable near-synchronous SR Ca
2+
 release, and thus contraction, throughout the cell (18, 21, 75 
28). The mechanism for the localization of ICa at the t-tubules is less clear, although it has 76 
been suggested that the caveolar protein, caveolin-3 (Cav-3) plays a role in the localization of 77 
ICa, possibly via a mechanism involving cyclic AMP/protein kinase A (PKA) signaling 78 
pathways (1, 5, 9, 24).  79 
Cav-3 is also involved in the localization of cyclic AMP signaling via β2-adrenoceptors 80 
to the t-tubules and it has been proposed that LTCC and β2-adrenoceptors are co-localized in 81 
a Cav-3 signaling microdomain (1, 5, 7, 23, 30). It has been shown that Cav-3 plays a critical 82 
role in the constitutive maintenance of ICa at the t-tubule (5).    In heart failure, there is 83 
redistribution of β2 adrenoceptors from the t-tubular to the surface membrane, so that they 84 
become more uniformly distributed across the cell membrane (22, 27). This redistribution is 85 
associated with a change from localized to more diffuse signaling in response to β2 adrenergic 86 
stimulation (27). We have recently shown in a coronary artery ligation (CAL) model in rat, 87 
that ventricular ICa is also redistributed from the t-tubules to the surface sarcolemma in heart 88 
failure (6).   89 
We hypothesize that the redistribution of ICa following CAL is due to loss of Cav-3 90 
dependent localization at the t-tubules, which may be secondary to the decreased expression 91 
of Cav-3 observed in HF. Thus, changes in the localization of the β2 signaling pathway in 92 
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heart failure may be associated with a loss of constitutive regulation of ICa by PKA at the t-93 
tubules. We have, therefore, investigated further the relationship between the distribution of 94 
ICa and changes in Cav-3/β2 adrenergic signaling observed following CAL in rats (6). 95 
  96 
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METHODS 97 
Animals and surgical procedures 98 
All procedures were performed in accordance with UK legislation and approved by the 99 
University of Bristol Ethics Committee.  The study was conducted in parallel with other 100 
investigations using cells from the same animals to investigate ventricular and atrial cellular 101 
remodeling in heart failure and thereby conformed to the reduction component of the 3Rs (3, 102 
6, 16).  Adult male Wistar rats (~250 g) were subject to either ligation of the left anterior 103 
descending coronary artery (CAL – 10 animals) or equivalent surgery without ligation (Sham 104 
– 12 animals). Operations were conducted under general anesthesia (ketamine 75 mg/kg, 105 
medetomidine 0.5 mg/kg, i.p.) with appropriate analgesia (buprenorphine 0.05 mg/kg, s.c.), 106 
as described previously (6).  Data regarding changes in cardiac morphology and function, and 107 
in cell morphology, in these groups of animals have been published previously (3, 6). 108 
Myocyte isolation 109 
Left ventricular myocytes were isolated from the hearts ~18 weeks following surgery as 110 
described previously (5). Animals were killed under pentobarbitone anesthesia, the heart 111 
quickly excised, and Langendorff-perfused at 8 mL/min (37ºC), initially with Tyrode’s 112 
solution (see below) plus 0.75 mmol/L CaCl2 for 4 minutes, then nominally Ca-free for 4 113 
minutes, and finally plus 1 mg/mL collagenase (Worthington Corp) for 10 minutes.  The left 114 
ventricle was then excised and shaken in collagenase-containing solution at 37 ºC for 5-7 115 
minutes, filtered, and centrifuged.  The supernatant was discarded and the pellet re-suspended 116 
in Kraftbrühe solution and stored at 4 °C for 2 - 10 h before use on the day of isolation (20).  117 
Detubulation (DT) of myocytes (physical and functional uncoupling of the t-tubules from the 118 
surface membrane) was achieved using formamide-induced osmotic shock, as described 119 
previously (21). 120 
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 121 
Solutions 122 
Tyrode’s solution for cell isolation contained (in mmol/L): 130 NaCl, 5.4 KCl, 0.4 NaH2PO4, 123 
4.2 HEPES, 10 glucose, 1.4 MgCl2, 20 taurine, 10 creatinine, pH 7.4 (NaOH).  The KB 124 
solution for cell storage contained (in mmol/L): 90 L-glutamic acid, 30 KCl, 10 HEPES, 1 125 
EGTA, 5 Na pyruvate, 20 taurine, 20 glucose, 5 MgCl2, 5 succinic acid, 5 creatine, 2 Na2ATP 126 
and 5 β–OH butyric acid; pH 7.4 with KOH. For patch-clamp experiments, cells were 127 
superfused with a solution that contained (in mmol/L): 133 NaCl, 1 MgSO4, 1 CaCl2, 1 128 
Na2HPO4, 10 glucose, 10 HEPES, pH 7.4 (NaOH); 5 CsCl was added to inhibit K currents.  129 
The pipette solution contained (in mmol/L): 110 CsCl, 20 TEACl, 0.5 MgCl2, 5 Mg-ATP, 5 130 
BAPTA, 10 HEPES, 0.4 GTP-Tris, pH 7.2 (CsOH); BAPTA was used to inhibit Ca-131 
dependent inactivation of ICa.(33) 132 
Selective β2-adrenoceptor stimulation was achieved as described previously (5) using 133 
the β2-adrenoceptor agonist zinterol (1 and 3 μmol/L) in the presence of the β1-adrenoceptor-134 
selective antagonist, atenolol (10 μmol/L); cells were superfused with atenolol alone for at 135 
least 4 min prior to superfusion with zinterol in the presence of atenolol.  Under these 136 
conditions, the effects of 1 and 3 μmol/L zinterol could be completely abolished by 100 nM 137 
ICI 118,551, a β2-adrenoceptor-selective antagonist (5). The plant alkaloid, forskolin (10 138 
μmol/L) was used to activate adenylyl cyclase directly (31).  C3SD, a short peptide 139 
encompassing the Cav-3 scaffolding domain, was used to disrupt binding of Cav-3 to its 140 
protein partners as described previously (5, 13, 15, 23); myocytes were incubated in 1 µmol/L 141 
TAT-C3SD for at least 45 minutes before use. PKA was inhibited using H-89 (20 μmol/L) 142 
(11, 17).   143 
 144 
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 145 
Recording and analysis of ICa   146 
Myocytes were placed in a chamber mounted on a Nikon Diaphot inverted microscope. 147 
Membrane currents and cell capacitance were recorded using the whole-cell patch-clamp 148 
technique, using an Axopatch 200B, Digidata 1322A A/D converter and pClamp 10 (Axon 149 
Instruments). Pipette resistance was typically 2-4 MΩ when filled with pipette solution, and 150 
pipette capacitance and series resistance were compensated by ~70%. Currents were activated 151 
from a holding potential of -80 mV by a 100 ms step depolarization to –40 mV (to inactivate 152 
the sodium current, INa) followed by steps to potentials between -50 and +80 mV for 500 ms, 153 
before repolarization to the holding potential, at a frequency of 0.2 Hz. ICa amplitude (pA) 154 
was measured as the difference between peak inward current and current at the end of the 155 
depolarizing pulse, and was normalized to cell capacitance (pF; a function of membrane area 156 
(25)) to calculate ICa density (pA/pF). Surface membrane current density was obtained from 157 
currents measured in DT myocytes, while t-tubular membrane current density was calculated 158 
by subtraction of surface from whole-cell currents and corrected for incomplete DT as 159 
described previously (5, 6, 19, 21). DT efficiency, measured from images of intact and DT 160 
cells stained with di-8-ANEPPS, was ~84%, and was not different between WT and CAL 161 
myocytes (6). To correct for incomplete detubulation, the distribution of membrane 162 
capacitance and ICa between the t-tubule and surface membrane was calculated as described 163 
previously (6). As we have reported previously, there was no statistically significant 164 
difference between Sham and CAL myocytes in the degree of osmotic shock-induced 165 
detubulation, nor was there any relationship between the whole-cell capacitance and the time 166 
of recording (6).  167 
Statistics 168 
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Data are expressed as mean ± SEM of n myocytes.  Statistical analysis was performed using 169 
GraphPad Prism (GraphPad Software Inc.).  ICa density-voltage relationship curves were 170 
analysed using repeated measures (RM) ANOVA with voltage and corresponding 171 
intervention (i.e. DT, H-89 or C3SD) as factors; ICa properties elicited by a step 172 
depolarization to a single voltage were analyzed by 2-way ANOVA; post hoc tests used 173 
Bonferroni correction.  The limit of statistical confidence was taken as p<0.05.  The errors in 174 
derived variables (specifically ICa density at the t-tubule membrane), and the subsequent 175 
statistical analysis (unpaired Student’s t-test) were calculated using propagation of errors 176 
from the source measurements (6, 14).  177 
 178 
 179 
  180 
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RESULTS 181 
The effect of CAL on the response to β2-adrenoceptor stimulation. 182 
In intact ventricular myocytes from Sham hearts, selective activation of β2-adrenoceptors (1 183 
and 3 μmol/L zinterol in the presence of 10 μmol/L atenolol) caused a significant, 184 
concentration-dependent, increase of ICa, which reached ~140% of control in the steady-state 185 
in the presence of 3 μmol/L of the β2-agonist (Figs. 1A, left panel, 1B and 1C). In contrast, in 186 
detubulated (DT) cells 3 μmol/L zinterol did not increase ICa (Figs. 1A, right panel, 1B and 187 
1C). In CAL myocytes, 3 μmol/L zinterol caused an increase of ~40% in intact cells and 188 
~29% in DT myocytes (Fig. 1 D – F). Thus, because ICa recorded in DT cell represents the 189 
current at the surface membrane, it appears that in Sham myocytes, the response of ICa to β2-190 
adrenoceptor stimulation occurs predominantly at the t-tubule membrane. However, 191 
following CAL the β2-adrenergic response redistributes, and occurs at both the cell surface 192 
and t-tubule membranes. These data also show that the DT procedure per se is not 193 
responsible for the lack of response to zinterol observed in Sham myocytes.   194 
The effect of CAL on the response to forskolin 195 
To investigate whether the distribution of the β2-adrenergic response was due to the 196 
localization of a downstream component of the signaling pathway, we used forskolin (10 197 
μmol/L) to activate adenylyl cyclase directly, to increase cyclic AMP in the absence of 198 
adrenoceptor stimulation. Superfusion with forskolin (10 μmol/L) increased ICa in both intact 199 
and DT myocytes from Sham hearts (Fig. 2A). The corresponding mean ICa density-voltage 200 
relationships for intact and DT myocytes are shown in Figure 2B. Figure 2C summarizes the 201 
effect of forskolin on ICa density at a test potential of -10 mV in Sham intact and DT 202 
myocytes. Forskolin also caused an increase in ICa in both intact and DT myocytes from CAL 203 
hearts (Figs. 2 D – F).  These data show that the increase in ICa in response to forskolin is 204 
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similar in intact Sham and CAL myocytes.  More importantly, these data also show that 205 
forskolin caused a significant increase in the amplitude of ICa in DT Sham myocytes, which 206 
was similar to that observed in DT CAL myocytes.  Thus, it appears that adenylyl cyclase and 207 
PKA are present at both the surface and t-tubule membranes in both Sham and CAL 208 
myocytes, and can stimulate ICa to a similar extent at either site. It is unlikely therefore that 209 
the lack of effect of zinterol in DT Sham myocytes was due to absence of the components of 210 
the cyclic AMP signaling pathway (i.e. adenylyl cyclase and PKA) at the cell surface, but 211 
may be due to the absence of β2-adrenoreceptors.  212 
The effect of CAL on the response to C3SD  213 
Since Cav-3 has been implicated in the localization of β2-adrenoceptor/cyclic AMP signaling 214 
at the t-tubules, we investigated the effect of acutely inhibiting Cav-3 binding to its partner 215 
proteins by pretreatment of cells with the C3SD peptide (5, 15). ICa density was reduced in 216 
intact Sham myocytes treated with the C3SD peptide (Figs. 3A left-hand panel, and 3B). 217 
However, treatment with C3SD had no effect on ICa density in DT Sham myocytes (Figs. 3A 218 
right panel, and 3C). The effects of treatment with C3SD on ICa density at 0 mV in intact and 219 
DT myocytes from Sham hearts are summarized in Figure 3D. In contrast to its effect in 220 
Sham myocytes, C3SD had no effect on ICa density in intact CAL myocytes (Figs. 3E left 221 
panel, 3F and 3H). Nor did C3SD have any effect on ICa in DT CAL myocytes (Figs. 3E right 222 
panel, 3G and 3H). Thus, there appears to be no Cav-3 dependent regulation of ICa at the 223 
surface membrane in either Sham or CAL myocytes. However, there does appear to be Cav-3 224 
dependent stimulation of ICa at the t-tubules of Sham myocytes, which is absent in CAL cells.   225 
The effect of CAL on the response to H-89 in the absence and presence of C3SD 226 
Since it has been suggested that Cav-3 dependent stimulation of t-tubular ICa is via a PKA-227 
dependent mechanism (5), we investigated the effect of the PKA inhibitor H-89 on ICa density 228 
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following CAL, and the effect of C3SD on the response to H-89.  Inhibition of PKA (20 229 
μmol/L H-89) decreased ICa in untreated and C3SD-treated Sham myocytes, indicating 230 
constitutive stimulation of ICa by PKA that did not require Cav-3 (Figs. 4A – C). Moreover, 231 
there was no difference in the ICa density-voltage relations of untreated and C3SD-treated 232 
cells in the presence of H-89 (Fig. 4B), demonstrating that the effects of H-89 and C3SD-233 
treatment were not summative. Thus, in the presence of PKA inhibition, treatment with C3SD 234 
peptide was without effect on ICa density, indicating that PKA activity was required for the 235 
constitutive regulation of ICa by Cav-3 in Sham myocytes. Similarly, H-89 decreased ICa 236 
density to the same level in both untreated and C3SD-treated CAL myocytes, indicating 237 
constitutive regulation of ICa by PKA (Figs. 4D – F). C3SD was without effect on ICa density 238 
in either the absence or presence of H-89 (Figs. 4E and 4F).  These data show that in Sham 239 
myocytes there is constitutive stimulation of ICa by PKA that is mediated both via Cav-3-240 
dependent (localized to the t-tubule membrane) and Cav-3-independent mechanisms. 241 
Although the constitutive regulation by Cav-3 was lost in CAL myocytes, constitutive 242 
regulation of ICa via PKA remained.  243 
The effect of detubulation on the constitutive regulation of ICa by PKA 244 
To investigate further the site of constitutive PKA-dependent regulation, the response to H-89 245 
was determined in DT myocytes. ICa density was reduced by H-89 in both intact and DT 246 
Sham myocytes (Figs. 5A – C). ICa density was also reduced by DT both in the presence or 247 
absence of PKA inhibition (Fig. 5C).  H-89 also reduced ICa density in intact and DT 248 
myocytes from CAL hearts (Figs. 5D – F). However, in contrast to Sham myocytes, in CAL, 249 
ICa density was similar in intact and DT myocytes either in the presence or absence of PKA 250 
inhibition (Fig. 5F). 251 
The calculated current densities at the cell surface and in the t-tubule membrane before and 252 
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after inhibition of PKA are shown in Figure 6.  These data show that in Sham myocytes, 253 
without inhibition of PKA, ICa density was significantly greater in the t-tubule membrane 254 
than at the cell surface, consistent with previous reports (5, 6, 16). In contrast, in CAL 255 
myocytes there was no difference in ICa density between t-tubule and surface membranes 256 
(Fig. 6B). Inhibition of PKA caused a broadly similar fractional decrease in ICa at the surface 257 
membrane in both Sham and CAL myocytes, so that surface membrane ICa remained larger in 258 
CAL than in Sham myocytes. Thus, constitutive stimulation of basal ICa by PKA at the cell 259 
surface was similar in the two cell types. H-89 also decreased t-tubular ICa density in both cell 260 
types so that it was smaller in CAL than in Sham myocytes. However, following inhibition of 261 
PKA, ICa density remained higher at the t-tubules than in the surface membrane in Sham 262 
myocytes whereas in CAL myocytes, ICa density was smaller at the t-tubules than at the 263 
surface membrane. Thus, it appears not only that ICa redistributes from the t-tubules to the 264 
cell surface in heart failure but also that constitutive regulation of t-tubular ICa by PKA is 265 
increased in these cells (cf. Fig. 6A and Fig. 6B).  266 
 267 
 268 
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DISCUSSION 269 
This study presents two novel findings regarding the regulation of ICa in heart failure: Firstly, 270 
stimulation of ICa by β2-adrenoceptors, but not by adenylyl cyclase/PKA, is localized to the t-271 
tubules in Sham myocytes, and redistributes to the cell surface following CAL. Secondly, it 272 
demonstrates constitutive stimulation of ICa by PKA in Sham myocytes that is mediated both 273 
via Cav-3-dependent (at the t-tubules) and Cav-3-independent mechanisms, whereas in CAL 274 
myocytes, constitutive regulation by Cav-3 is lost although that via PKA remains at both 275 
sites. Thus, the study advances previous findings from our laboratory that Cav-3 plays a role 276 
in the regulation of ICa at the t-tubule by PKA and β2-adrenoceptors in normal myocytes (5, 9) 277 
and that ICa is redistributed from the t-tubules to the surface sarcolemma in CAL-induced 278 
heart failure (6). Interestingly, although constitutive PKA-dependent stimulation of ICa at the 279 
cell surface appeared to be the same in both Sham and CAL myocytes, constitutive 280 
stimulation of t-tubular ICa appeared to increase in CAL myocytes, helping to maintain t-281 
tubular ICa. Figure 7 shows schematic diagrams illustrating the regulation of ICa by β2-282 
adrenoceptors, Cav-3 and PKA in normal cells (panel A) and in heart failure (panel B). 283 
 284 
Localization of ICa Regulation by PKA in Sham myocytes 285 
The Cav1.2 pore-forming α-subunit of ventricular LTCCs has been shown to be 286 
colocalized with Cav-3, adenylyl cyclase, PKA and the β2-adrenoceptor (1).  Stimulation of 287 
β2-adrenoceptors in cardiac myocytes activates adenylyl cyclase, causing a local increase of 288 
cyclic AMP, activation of PKA and thereby phosphorylation and stimulation of co-localized 289 
LTCCs (1). The present data show that β2-adrenoceptor stimulation of ICa in Sham myocytes 290 
occurs predominantly at the t-tubules (Figure 1), although direct activation of adenylyl 291 
cyclase using forskolin increased ICa at both the t-tubular and surface membranes (Figure 2). 292 
Thus, in normal myocytes, adenylyl cyclase and the downstream pathway is present at both 293 
15 
 
the t-tubular and surface membranes, but the β2-adrenoceptor is present only at the t-tubules, 294 
consistent with previous work showing t-tubular localization of β2-adrenoceptor signaling in 295 
normal ventricular myocytes (27).  Pretreatment with the C3SD peptide decreased basal ICa at 296 
the t-tubules but not at the surface membrane in Sham myocytes (Figure 3), showing that 297 
Cav-3 plays a role in the constitutive stimulation of ICa at the t-tubules, but not at the surface 298 
membrane in normal cells (Fig. 7A). These data are entirely consistent with our previous 299 
report in which we showed that pretreatment with C3SD abolished both the constitutive 300 
regulation of ICa at the t-tubule and the response to β2-adrenoceptors in myocytes from 301 
unoperated animals (5).  In contrast, inhibition of PKA using H-89 in the present study 302 
decreased ICa at both the surface and t-tubule membranes, presumably reflecting the loss of 303 
tonic activity of the adenylyl cyclase/cyclic AMP/PKA pathway at both the surface and t-304 
tubular membranes (Fig. 5, and summarized in Fig. 7A).  Although it has been suggested that 305 
H-89 may have non-specific effects independent of PKA inhibition (26), we have previously 306 
shown that basal ICa was decreased by the peptide inhibitor of PKA, PKI (9). Moreover, we 307 
have recently shown that H-89 was without effect on basal ICa in rat atrial myocytes from the 308 
same hearts as used in the present study, demonstrating both regional differences in the role 309 
of PKA in the regulation of ICa and that H-89 was without direct effect on L-type Ca
2+
 310 
channel currents per se (3). The regulation of basal ICa by constitutive PKA activity has also 311 
been demonstrated previously in rat ventricular myocytes (4, 5, 9).  312 
While the inhibitory effect of H-89 in Sham myocytes was not abolished by 313 
pretreatment of the cells with C3SD, H-89 reduced basal ICa to the same mean amplitude in 314 
C3SD-treated and untreated cells (Figure 4), indicating that the effects of C3SD and H-89 315 
were not summative. Thus, PKA is required for the constitutive regulation of ICa by Cav-3 at 316 
the t-tubules in Sham myocytes, but there is an additional Cav-3-independent constitutive 317 
regulation of ICa by PKA. As basal ICa density in detubulated Sham myocytes was reduced by 318 
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H-89, but not by C3SD, it can be concluded that PKA is also involved in the constitutive 319 
regulation of ICa at the surface sarcolemma through a mechanism independent of Cav-3.  320 
Taken together, these data suggest a role for Cav-3 in co-ordinating a complex of signaling 321 
proteins including LTCC, PKA and the β2-adrenoceptor at the t-tubule membrane in normal 322 
ventricular myocytes (1, 5, 27).  While Cav-3 is important to the constitutive maintenance of 323 
ICa by PKA at the t-tubule in normal ventricular myocytes, it does not appear to be required 324 
for localizing ICa density at the t-tubule membrane because the difference in ICa density 325 
between t-tubule and surface sarcolemma was maintained following inhibition of PKA (Fig. 326 
6A).  327 
 328 
Regulation of ICa by PKA in CAL myocytes 329 
In contrast to Sham myocytes, ICa increased in response to β2 adrenergic stimulation in 330 
both intact and DT CAL myocytes (Figure 1). Moreover, C3SD had no effect on ICa in CAL 331 
myocytes (Figure 3). However, as in Sham myocytes, forskolin increased (Figure 2), and H-332 
89 decreased (Figures 4, 5 & 6), ICa at both the surface and t-tubular membranes. The 333 
simplest explanation of these data is that the normal Cav-3-dependent localization of β2-334 
adrenoceptor signaling at the t-tubules is disrupted in CAL myocytes, so that the β2-335 
adrenoceptor is distributed across both the surface and t-tubular membranes, and can 336 
stimulate adenylyl cyclase/PKA and thus LTCCs at both sites, even without Cav-3 337 
regulation; this is consistent with the redistribution of β2-adrenoceptor cyclic AMP signaling 338 
in heart failure (27) and demonstrates that Cav-3 is not required for β2-adrenoceptor 339 
stimulation of adenylyl cyclase/PKA, which are already present at both sites (Fig. 7B).  340 
Interestingly, in the presence of H-89, ICa density was similar in the t-tubular and surface 341 
membranes of CAL myocytes, suggesting that LTCCs are also redistributed in heart failure 342 
(6).  The mechanisms underlying the redistribution of β2-adrenoceptors and LTCCs away 343 
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from the t-tubules, resulting in a more uniform distribution across the cell membrane, are 344 
unclear; presumably the redistribution of Cav-3 to non-cholesterol-rich membranes in heart 345 
failure leads to a loss of Cav-3 from the t-tubules and consequent disruption of Cav-3-346 
dependent complexes containing LTCC/adenylyl cyclase/PKA/β2-adrenoceptors (29). Cav-3 347 
likely plays a role in the localization of the β2-adrenoceptor to the t-tubule so that the loss of 348 
Cav-3 regulation from the t-tubule membrane in heart failure contributes directly to the re-349 
distribution of the receptor to the surface sarcolemma and the loss of localization of β2-350 
adrenoceptor signaling to the t-tubule in failing myocytes (1, 5, 27, 32). Alternatively, in 351 
principle, it is possible that β2-adrenoceptors are more uniformly distributed between the t-352 
tubule and surface membranes and that Cav-3 may be responsible for the localization of 353 
adenylyl cyclase/PKA signaling to the β2-adrenoceptors in the t-tubules. Consistent with 354 
either of these proposals, treatment of normal ventricular myocytes with the C3SD peptide 355 
has been shown to antagonize β2-adrenoceptor-mediated increases in ICa (5). Moreover, over-356 
expression of Cav-3 restored the localization of β2-adrenoceptor signaling to the t-tubules in 357 
failing cells, implying a direct role for Cav-3 in the localization of the receptors and/or 358 
receptor signaling to the t-tubules, presumably via binding with the scaffolding domain (32). 359 
However, the observation that zinterol stimulates ICa at the surface membrane of CAL 360 
myocytes, in which C3SD has no effect on ICa, suggests that β2-adrenoceptor stimulation can 361 
stimulate adenylyl cyclase/PKA even without Cav-3 binding. The role of Cav-3 in the loss of 362 
t-tubular localization of β2-adrenoceptor signaling in heart failure might be tested in future 363 
studies by investigating the effect of the C3SD peptide on the response of CAL myocytes to 364 
β2 stimulation. On the other hand, Cav-3 does not seem to play a direct role in the localization 365 
of LTCC to the t-tubule because (i) interference of Cav-3 binding to its partners in intact 366 
Sham myocytes by treatment with the C3SD peptide had no effect on ICa in the presence of 367 
PKA inhibition (Fig. 4), indicating that PKA activity was required for the Cav-3-dependent 368 
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regulation of LTCC and (ii) PKA was not required for the concentration of ICa at the t-tubule 369 
in Sham myocytes (Fig. 4). Although Cav-3-dependent regulation of t-tubular ICa by PKA 370 
was lost in CAL myocytes, they showed an increased ratio of basal t-tubular ICa density to t-371 
tubule ICa density in the presence of H-89, compared to Sham myocytes (CAL, basal -5.9 ± 372 
1.6, H-89 -1.7 ± 0.8 pA/pF; Sham, basal -12.9 ± 3.0, H-89 -7.4 ± 1.6 pA/pF), indicating that 373 
the contribution of PKA to the maintenance of t-tubular ICa was augmented in heart failure. 374 
This is consistent with increased PKA-dependent regulation of basal whole-cell ICa in failing 375 
human ventricular myocytes (10).  Nevertheless, the mechanism for the increased constitutive 376 
regulation of t-tubular ICa by PKA in heart failure remains unclear.  377 
Functional implications of regulation of ICa by PKA 378 
Previous work has shown that ICa occurs predominantly in the t-tubules, in close 379 
proximity to RyRs in the SR membrane, allowing efficient coupling between Ca entry via ICa 380 
and Ca release from the SR. The present work shows that even in the presence of PKA 381 
inhibition, ICa still occurs predominantly in the t-tubules of Sham myocytes, suggesting a 382 
higher concentration of LTCCs in the t-tubules. The observation that β2-adrenoceptor 383 
stimulation of ICa is normally localized to the t-tubules is consistent with the importance of 384 
this site for the normal regulation of excitation-contraction coupling, and the potential 385 
detrimental effects of a whole-cell increase of cAMP. 386 
In CAL myocytes, although there was little change in whole cell ICa density, there was 387 
redistribution of ICa so that it was more uniformly distributed across the surface and t-tubular 388 
membranes. Unless accompanied by parallel redistribution of RyRs which, to the best of our 389 
knowledge does not occur, the reduced Ca entry at the t-tubules will result in less effective 390 
coupling of Ca entry and release, and increased numbers of “orphaned” RyRs, resulting in a 391 
smaller slower Ca transient and thus contraction. However, the present work shows that 392 
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increased local constitutive stimulation of ICa by PKA helps to maintain ICa at the t-tubules, 393 
which will help ameliorate these deleterious effects.   394 
It has been proposed that a sub-population of LTCCs in surface membrane caveolae 395 
play a role in cardiac hypertrophy (12, 24). The observation that C3SD has little effect on ICa 396 
in DT Sham or CAL myocytes suggests that Cav-3 binding has little effect on LTCC function 397 
at the cell surface, although it remains possible that downstream effects of ICa are altered.  398 
Summary 399 
 The present study shows that Cav-3 plays a vital role in the co-ordination of PKA-400 
dependent regulation of both basal and β2-adrenoceptor stimulation of ICa in myocytes from 401 
healthy hearts. The co-localization by Cav-3 is lost in heart failure and both β2-adrenoceptors 402 
and LTCC are redistributed from the t-tubular to the surface sarcolemma membranes. The 403 
role of Cav-3 in the redistribution in heart failure remains unclear but the data are consistent 404 
with a shift in Cav-3 from cholesterol-rich to non-cholesterol-rich membranes (29). 405 
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FIGURE LEGENDS  412 
Figure 1. β2-adrenergic potentiation of ICa in Sham and CAL myocytes. A Representative ICa 413 
traces (elicited by step depolarization to 0 mV) recorded from intact and detubulated (DT) 414 
myocytes isolated from Sham hearts.  Overlapping traces are from the same cell and recorded 415 
under control conditions and after the application of 1 µmol/L and 3 µmol/L zinterol (in the 416 
presence of 10 µmol/L atenolol). The vertical scale bar = 1 nA and the horizontal scale bar = 417 
50 ms.  B Time course of changes in mean normalized peak ICa (±SEM) of intact (filled 418 
symbols, n=5) and DT (open symbols, n=6) Sham myocytes during superfusion with control 419 
solution (containing 10 μmol/L atenolol) and 1 & 3 µmol/L zinterol. ICa, elicited by step 420 
depolarization to 0 mV at 0.1 Hz, was expressed as a percentage of control measured just 421 
before the application of the first concentration of zinterol.  C Mean changes in ICa elicited by 422 
the application of 1 & 3 µmol/L zinterol to intact (filled bar, 1 μmol/L n=7; 3 μmol/L n=9) 423 
and DT (open bar, 1 μmol/L n=7; 3 μmol/L n=9] Sham myocytes. Data were subject to two-424 
way ANOVA: β2-agonism p<0.001, DT p<0.001; interaction p<0.001. * = p<0.05, *** = 425 
p<0.001; Bonferroni post hoc test. D Representative ICa traces (elicited by step depolarization 426 
to 0 mV) recorded from intact and DT myocytes isolated from CAL hearts.  Conditions and 427 
scale as in A. E Time course of changes in mean normalized peak ICa of intact (filled 428 
symbols, n=5) and DT (open symbols, n=4) CAL myocytes during superfusion with control 429 
solution (containing 10 μmol/L atenolol) and 1 & 3 μmol/L zinterol. F Mean changes in ICa 430 
elicited by the application of 1 & 3 µmol/L zinterol to intact (filled bar, 1 μmol/L n=5; 3 431 
μmol/L n=19) and DT (open bar, 1 μmol/L n=4; 3 μmol/L n=8] CAL myocytes.  Data were 432 
subject to two-way ANOVA: β2-agonism p<0.001, DT ns, interaction ns. ** = p<0.01, *** = 433 
p<0.001; Bonferroni post hoc test. 434 
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Figure 2. Increase in ICa through direction activation of adenylyl cyclase in Sham and CAL 435 
myocytes. A Representative ICa traces (elicited by step depolarization to 0 mV) recorded in 436 
the absence and presence of forskolin (10 μmol/L and 0.5 mmol/L CaCl2) from intact and DT 437 
myocytes isolated from Sham hearts.  Overlapping traces are taken from the same myocytes 438 
under control conditions and after 3 min perfusion with forskolin (FSK). Vertical scale bar = 439 
2 pA/pF and horizontal scale bar = 100 ms. B Mean ICa density-voltage relationships from 440 
intact (circles, n=12) and DT (squares, n=14) Sham myocytes in the absence (open symbols) 441 
and presence (filled symbols) of FSK.  ns, p>0.05, *, p<0.05; two-way ANOVA with 442 
Bonferroni post hoc test, intact vs DT cells. C The effect of FSK on peak ICa density (elicited 443 
at -10 mV) recorded in intact and DT Sham myocytes. Data were subject to two-way 444 
ANOVA: FSK p<0.001, DT p<0.01, interaction ns. *** = p<0.001; Bonferroni post hoc test. 445 
D Representative ICa traces recorded in the absence and presence of FSK (10 μmol/L and 0.5 446 
mmol/L CaCl2) from intact and DT myocytes isolated from CAL hearts. Conditions and scale 447 
as in A. E Mean ICa density-voltage relationships from intact (circles, n=18) and DT (squares, 448 
n=12) CAL myocytes in the absence (open symbols) and presence (filled symbols) of FSK.  449 
ns, p>0.05, *, two-way ANOVA with Bonferroni post hoc test, intact vs DT cells. F The 450 
effect of FSK on peak ICa density (elicited at -10 mV) recorded in intact and DT CAL 451 
myocytes. Data were subject to two-way ANOVA: FSK p<0.001, DT p<0.01, interaction ns. 452 
*** = p<0.001; Bonferroni post hoc test.   453 
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Figure 3. Constitutive regulation of basal ICa by caveolin-3.  A Representative ICa traces 454 
recorded from intact and DT myocytes isolated from Sham hearts.  Overlapping traces are 455 
taken from different myocytes that had either undergone incubation with the peptide C3SD (1 456 
µmol/L) or were untreated. The vertical scale bar = 2 pA/pF and the horizontal scale bar = 457 
100 ms. B Mean ICa density-voltage relations from untreated intact Sham cells (open circles, 458 
n=16) and intact Sham cells treated with the C3SD peptide (filled circles, n=16). **, p<0.01; 459 
two-way ANOVA with Bonferroni post hoc test, untreated vs C3SD-treated cells. C Mean ICa 460 
density-voltage relations from untreated Sham DT cells (open squares, n=20) and Sham DT 461 
cells treated with the C3SD peptide (filled squares, n=10).  ns, p>0.05; two-way ANOVA 462 
with Bonferroni post hoc test, untreated vs C3SD treated cells.  D The effect of C3SD on 463 
peak ICa density (elicited at 0 mV) recorded from Intact and DT, Sham myocytes. Data were 464 
subject to two-way ANOVA: C3SD ns, DT p<0.001, interaction p<0.01. ** = p<0.01, *** = 465 
p<0.001; Bonferroni post hoc test.   E Representative ICa traces recorded from intact and DT 466 
myocytes isolated from CAL hearts.  Conditions and scale as in A and overlapping traces are 467 
taken from different myocytes that had either undergone incubation with the peptide C3SD (1 468 
µmol/L) or were untreated. F Mean ICa density-voltage relations from untreated intact CAL 469 
cells (open circles, n=14) and intact CAL cells treated with the C3SD peptide (filled circles, 470 
n=15).  ns, p>0.05; two-way ANOVA with Bonferroni post hoc test, untreated vs C3SD 471 
treated cells.  G Mean ICa density-voltage relations from untreated DT CAL cells (open 472 
squares, n=22) and DT CAL cells treated with the C3SD peptide (filled squares, n=7).  ns, 473 
p>0.05; two-way ANOVA with Bonferroni post hoc test, untreated vs C3SD treated cells.   H 474 
The effect of C3SD on peak ICa density (elicited at 0 mV) recorded from Intact and DT, CAL 475 
myocytes. Data were subject to two-way ANOVA: C3SD ns, DT ns, interaction ns. 476 
 477 
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Figure 4. The role of PKA in caveolin-3-dependent regulation of basal ICa in Sham and CAL 478 
myocytes.  A Representative ICa traces recorded from intact untreated (Control) and C3SD-479 
treated (C3SD) myocytes isolated from Sham hearts.  Overlapping traces are taken from the 480 
same myocytes before and after the application of the PKA inhibitor H-89 (20 µmol/L). The 481 
vertical scale bar = 2 pA/pF and the horizontal scale bar = 100 ms.  B Mean ICa-density 482 
voltage-relationship curves recorded from intact myocytes isolated from Sham hearts that 483 
were either untreated (open symbols, n=16) or treated with C3SD (filled symbols, n=16) 484 
before (circles) and after (squares) the application of H-89. The control data is the same as 485 
that shown in Figure 3B.  ***, p<0.001; two-way ANOVA with Bonferroni post hoc test 486 
absence vs presence of H-89.  C The effect of PKA inhibition on mean peak ICa density 487 
(elicited at 0 mV) in Sham myocytes that were untreated (open bars) or treated (filled bars) 488 
with C3SD.  Data were subject to two-way ANOVA: C3SD ns, H-89 p<0.001, interaction ns. 489 
* = p<0.05, ** = p<0.01, *** = p<0.001, Bonferroni post hoc test.  D Representative ICa 490 
traces recorded from untreated and C3SD-treated myocytes isolated from CAL hearts before 491 
and after the application of the PKA inhibitor H-89 (20 µmol/L). Conditions and scale as A. 492 
E Mean ICa-density voltage relationship curves recorded from intact myocytes isolated from 493 
CAL hearts that were either untreated (open symbols, n=14) or treated with C3SD (filled 494 
symbols, n=15) before (circles) and after (squares) the application of H-89.  The control data 495 
is the same as that shown in Figure 3F.  ***, p<0.001; two-way ANOVA with Bonferroni 496 
post hoc test absence vs presence of H-89. F The effect of PKA inhibition on mean peak ICa 497 
density (elicited at 0 mV) in CAL myocytes that were treated (filled bars) or untreated (open 498 
bars) with C3SD.  Data were subject to two-way ANOVA: C3SD ns, H-89 p<0.001, 499 
interaction ns. *** = p<0.001; Bonferroni post hoc test. 500 
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Figure 5. The localization of PKA-dependent regulation of basal ICa in Sham and CAL 501 
myocytes.  A Representative ICa traces recorded from intact and DT myocytes isolated from 502 
Sham hearts.  Overlapping traces are taken from the same myocytes before and after the 503 
application of the PKA inhibitor H-89 (20 µmol/L). The vertical scale bar = 2 pA/pF and the 504 
horizontal scale bar = 100 ms.  B Mean ICa-density voltage-relationship curves recorded from 505 
myocytes isolated from Sham hearts that were either intact (circles, n=17) or DT (squares, 506 
n=8) before (open symbols) and after (filled symbols) the application of H-89. ***, p<0.001; 507 
two-way ANOVA with Bonferroni post hoc test control vs H-89. C The effect of PKA 508 
inhibition on mean peak ICa density (elicited at 0 mV) in intact or DT Sham myocytes under 509 
control conditions (open bars) or after PKA inhibition (H-89, filled bars).  Data were subject 510 
to two-way ANOVA: H-89 p<0.001, DT p<0.001, interaction p<0.05. *** = p<0.001; 511 
Bonferroni post hoc test.  D Representative ICa traces recorded from intact and DT myocytes 512 
isolated from CAL hearts; overlapping traces are taken from the same myocytes before and 513 
after the application of the PKA inhibitor H-89. Conditions and scale as A. E Mean ICa-514 
density voltage-relationship curves recorded from myocytes isolated from CAL hearts that 515 
were either intact (circles, n=14) or DT (squares, n=9) before (open symbols) and after (filled 516 
symbols) the application of H-89. ***, p<0.001; two-way ANOVA with Bonferroni post hoc 517 
test control vs H-89. F The effect of PKA inhibition on mean peak ICa density (elicited at 0 518 
mV) in intact or DT Sham myocytes under control conditions (open bars) or after PKA 519 
inhibition (H-89, filled bars).  Data were subject to two-way ANOVA: H-89 p<0.001, DT ns, 520 
interaction ns. *** = p<0.001; Bonferroni post hoc test. 521 
  522 
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Figure 6. A Mean ICa density at 0 mV measured in intact (‘total cell membrane’) and 523 
detubulated cells (‘Surface membrane’) and calculated at the t-tubules (‘t-tubule membrane’) 524 
for Sham myocytes. Correction for incomplete detubulation has been applied (see Methods). 525 
Open (left) columns are in control conditions and filled (right) columns are in the presence of 526 
H-89. B Mean ICa density at 0 mV measured in intact (‘total cell membrane’) and detubulated 527 
cells (‘Surface membrane’) and calculated at the t-tubules (‘t-tubule membrane’) for CAL 528 
myocytes.  Correction for incomplete detubulation has been applied (see Methods). Open 529 
(left) columns are in control conditions and filled (right) columns are in the presence of H-89.  530 
*p<0.05, **p<0.01, Student’s t test. 531 
Figure 7. A schematic summarizing the role of caveolin-3 (Cav-3) in the regulation of ICa in 532 
normal ventricular myocytes and in heart failure.  A Regulation of ICa in normal cardiac 533 
myocytes.  LTCC density is greatest in the t-tubules, where Cav-3 co-ordinates a signaling 534 
domain involving β2-adrenoceptors (β2AR), adenylyl cyclase (Ad Cyc), PKA and the LTCC 535 
α1c-subunit, Cav1.2. β2AR coupled with LTCC are located exclusively in the t-tubules. Ad 536 
Cyc, PKA and Cav1.2 are also located outside of Cav-3 signaling domains, both within and 537 
without t-tubules. Activation of Ad Cyc, either via β2AR or directly, augments LTCC activity 538 
through production of cAMP.  B Remodeling of ICa regulation in heart failure. The Cav-3 539 
signaling complex is disrupted. β2AR are located both within the t-tubules and on the surface 540 
sarcolemma. LTCC density is more evenly distributed between t-tubules and surface 541 
sarcolemma. The role of Cav-3 in the regulation of ICa is lost in heart failure. The schematic 542 
represents the simplest explanation of the data. Other mechanisms are possible; for example, 543 
β2AR may be located in both the cell surface and t-tubule membranes in normal cardiac 544 
myocytes but the coupling of β2AR with LTCC confined to the t-tubules. 545 
 546 
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